CanSino Biologics Statistics
Total Valuation
BST:CJH has a market cap or net worth of EUR 1.53 billion. The enterprise value is 1.36 billion.
| Market Cap | 1.53B |
| Enterprise Value | 1.36B |
Important Dates
The next confirmed earnings date is Monday, March 30, 2026.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 132.67M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.32% |
| Shares Change (QoQ) | +59.67% |
| Owned by Insiders (%) | 31.39% |
| Owned by Institutions (%) | 7.69% |
| Float | 159.11M |
Valuation Ratios
The trailing PE ratio is 451.32 and the forward PE ratio is 34.82.
| PE Ratio | 451.32 |
| Forward PE | 34.82 |
| PS Ratio | 11.78 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 401.75 |
| EV / Sales | 10.36 |
| EV / EBITDA | 52.88 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 6.81 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.57% and return on invested capital (ROIC) is 0.67%.
| Return on Equity (ROE) | 0.57% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.67% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 117,681 |
| Profits Per Employee | 3,072 |
| Employee Count | 1,115 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -746,982 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.96% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.96% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 5.55 |
| Relative Strength Index (RSI) | 49.87 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BST:CJH had revenue of EUR 130.04 million and earned 3.39 million in profits. Earnings per share was 0.01.
| Revenue | 130.04M |
| Gross Profit | 130.04M |
| Operating Income | 2.91M |
| Pretax Income | 2.65M |
| Net Income | 3.39M |
| EBITDA | 25.49M |
| EBIT | 2.91M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 339.87 million in cash and 173.57 million in debt, with a net cash position of 166.30 million.
| Cash & Cash Equivalents | 339.87M |
| Total Debt | 173.57M |
| Net Cash | 166.30M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 600.49M |
| Book Value Per Share | 3.29 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 2.24% and 2.61%.
| Gross Margin | 100.00% |
| Operating Margin | 2.24% |
| Pretax Margin | 2.04% |
| Profit Margin | 2.61% |
| EBITDA Margin | 19.60% |
| EBIT Margin | 2.24% |
| FCF Margin | n/a |
Dividends & Yields
BST:CJH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.32% |
| Shareholder Yield | -2.32% |
| Earnings Yield | 0.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |